tm
Seeing Is Believing
tm
Seeing Is Believing
SLN is currently covered by 2 analysts with an average price target of $32. This is a potential upside of $12.33 (62.68%) from yesterday's end of day stock price of $19.67.
Silence Therapeutics PLC's activity chart (see below) currently has 47 price targets and 64 ratings on display. The stock rating distribution of SLN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 39.05% with an average time for these price targets to be met of 119.8 days.
Highest price target for SLN is $32, Lowest price target is $32, average price target is $32.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 11-Aug-2026. First documented stock forecast 17-Nov-2020.
Currently out of the existing stock ratings of SLN, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-May-2023
$32
$23.32 (268.66%)
$25
2 months 11 days ago
(11-Aug-2026)
6/12 (50%)
$17.28 (117.39%)
223
Buy Since 05-Dec-2022
4 months 5 days ago
(17-Jun-2026)
0/11 (0%)
$55.91 (292.88%)
Buy Since 31-Mar-2022
1 years 4 months 9 days ago
(13-Jun-2025)
2/7 (28.57%)
$48.67 (768.88%)
277
Sell Since 10-Feb-2025
$3
$-5.68 (-65.44%)
$4
1 years 5 months 13 days ago
(09-May-2025)
2/3 (66.67%)
$-0.7 (-18.92%)
72
Buy Since 17-Nov-2020
$15
$6.32 (72.81%)
$32
2 years 11 months 7 days ago
(14-Nov-2023)
1/2 (50%)
$5.58 (59.24%)
27
What is SLN (Silence Therapeutics PLC) average time for price targets to be met?
Which analyst most recently updated their price target on SLN (Silence Therapeutics PLC)?
Which analyst has the current lower performing score on SLN (Silence Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most bullish on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most reserved on SLN (Silence Therapeutics PLC)?
